Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $114,976 - $184,274
-1,336 Reduced 33.4%
2,664 $248,000
Q1 2023

May 09, 2023

SELL
$104.0 - $122.92 $23,400 - $27,657
-225 Reduced 5.33%
4,000 $464,000
Q4 2022

May 09, 2023

SELL
$84.98 - $122.67 $108,349 - $156,404
-1,275 Reduced 23.18%
4,225 $478,000
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $419,924 - $517,990
5,500 New
5,500 $385,000
Q2 2022

Aug 10, 2022

SELL
$67.99 - $132.89 $67,990 - $132,890
-1,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $41,677 - $57,678
443 Added 79.53%
1,000 $512,000
Q4 2021

Feb 15, 2022

BUY
$129.87 - $162.82 $14,935 - $18,724
115 Added 26.02%
557 $303,000
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $11,524 - $15,463
108 Added 32.34%
442 $242,000
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $15,288 - $20,482
-196 Reduced 36.98%
334 $123,000
Q3 2020

Nov 10, 2020

BUY
$95.51 - $112.95 $3,247 - $3,840
34 Added 6.85%
530 $219,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $1,880 - $3,160
30 Added 6.44%
496 $201,000
Q1 2020

May 12, 2020

BUY
$47.79 - $75.63 $19,354 - $30,630
405 Added 663.93%
466 $126,000
Q4 2019

Feb 11, 2020

BUY
$36.62 - $57.29 $2,233 - $3,494
61 New
61 $13,000
Q2 2019

Aug 06, 2019

SELL
$27.84 - $38.92 $1,531 - $2,140
-55 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $224 - $305
-8 Reduced 12.7%
55 $7,000
Q4 2018

Feb 11, 2019

BUY
$26.99 - $37.37 $377 - $523
14 Added 28.57%
63 $8,000
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $1,144 - $1,799
49 New
49 $7,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.